Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients-Reference-Cited by-同舟云学术

Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients

Published:2013-05-09 Issue:8 Volume:133 Page:1994-2003
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Farnebo Lovisa¹,Tiefenböck Katharina¹,Ansell Anna²,Thunell Lena K.³,Garvin Stina,Roberg Karin

Affiliation:

1. Department of ENT-Head and Neck Surgery; UHL, County Council of Östergötland; Linköping; Sweden

2. Division of Oto-Rhino-Laryngology and Head and Neck Surgery; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University; Linköping; Sweden

3. Division of Cell Biology; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University; Linköping; Sweden

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference56 articles.

1. Recent advances in head and neck cancer;Haddad;N Engl J Med,2008

2. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines;Farnebo;J Oral Pathol Med,2011

3. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines;Farnebo;Oncol Rep,2008

4. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

5. Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors;Bergkvist;Cancer Biol Ther,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma;Head & Neck;2024-02-02

2. Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma;Translational Oncology;2024-01

3. Insight on common forms of cutaneous head and neck carcinoma (Review);Molecular and Clinical Oncology;2023-02-17

4. Are the common genetic 3’UTR variants in ADME genes playing a role in tolerance of breast cancer chemotherapy?;2022-12-05

5. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma;Frontiers in Oncology;2022-10-21